Lilly Announces New Investment at the BIO Convention
This multi-million dollar investment is further fueling research and development of multi-specific therapeutics.
Eli Lilly and Company announced yesterday at the BIO International Convention a multi-million dollar investment to expand its existing biotechnology capabilities.
This investment is further fueling research and development of multi-specific therapeutics, in which two or more distinct mechanisms of action are engineered in one molecule with the goal of providing enhanced efficacy with an improved safety profile.
Lilly already has several multi-specific therapeutics in preclinical development, including a co-agonist peptide being studied as a potential treatment for diabetes that is anticipated to enter clinical development by the end of this year. Lilly is hiring additional biochemists and biologists to further support its important work in multi-s
Related News
-
News Women in Pharma: Unlocking patient inclusion at CPHI Americas
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can towards making the healthcare industry and workplace more equitable and inclusive.&nbs... -
News Tracking Innovation with Thermo Fisher Scientific: CPHI Americas Track Sponsor interview
As we gear up for CPHI Americas from May 20-22, 2025 at the Philadelphia Convention Center, we sat down with Track Sponsor Thermo Fisher Scientific to discuss the future of bioproduction in pharma.
-
News Say hello to the CPHI Exhibitor Spotlight!
We’re kicking off a brand-new series where we shine the spotlight on some of the amazing companies gearing up to shake things up at CPHI Americas 2025 this May! The first company in our spotlight is TAPI, who are set to make a splash at its ve... -
News A Day at CPHI Americas 2025 – What to Expect
CPHI returns to Philadelphia from May 20-22, 2025 under a new name – CPHI Americas. As we aim to bring together pharma professionals for 3 days of innovation and collaboration, CPHI Americas 2025 hopes to recognise the growing influence of the Am... -
News DCAT 2025 insights and learnings with Thermo Fisher Scientific
DCAT Week 2025, held March 17-20, 2025 in New York City, provides an opportunity for the global bio/pharmaceutical manufacturing value chain to come together and discuss the emerging trends and opportunities in the manufacturing supply chain.
-
News Women in Pharma: Career Design for Women
Our monthly Women in Pharma series highlights the influential lives and works of impactful women working across the pharmaceutical industry, and how the industry can work towards making the healthcare industry and workplace more equitable and inclusive... -
News Pfizer may shift production back to US under Trump pharma tariffs
At the 45th TD Cowen annual healthcare conference in Boston, USA, Pfizer CEO Albert Bourla outlined the potential for Pfizer to shift its overseas drug manufacturing back to the US as pharmaceutical industry players weigh their options against Presiden... -
News Women in Pharma: Connecting accessible pharma packaging to patients – a Pharmapack Special
Throughout our Women in Pharma series, we aim to highlight how CPHI events encourage discussions around diversity, equity, and inclusion initiatives in the pharmaceutical industry.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance